Cabot Corporation (NYSE:CBT) Receives Consensus Recommendation of "Hold" from Brokerages

Key Points

• Cabot has a consensus “Hold” rating from seven analysts: four rate it a hold, two a buy and one a sell. The average 12-month price target is $89, modestly above the reported share price of $86.58.
• Cabot’s latest quarter slightly exceeded expectations, with EPS of $1.67 versus $1.66 expected and revenue of $982 million, up 6.4% year over year. Management issued fiscal 2026 EPS guidance of $6.15–$6.45.
• The company declared a quarterly dividend of $0.4725, equivalent to $1.89 annually and a 2.2% yield. CEO Sean Keohane sold 91,923 shares, while institutional investors collectively own 93.18% of the stock.

Cabot Corporation (NYSE:CBT - Get Free Report) has been given an average rating of "Hold" by the seven research firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $89.00.

Several equities analysts recently commented on CBT shares. Wall Street Zen upgraded Cabot from a "hold" rating to a "buy" rating in a research note on Sunday. Truist Financial set a $100.00 price objective on shares of Cabot in a research report on Wednesday, August 5th. UBS Group lowered their target price on Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a research note on Wednesday, August 5th. Weiss Ratings restated a "hold (c)" rating on shares of Cabot in a research note on Tuesday, May 26th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research note on Friday, August 7th.

Insider Buying and Selling

In other Cabot news, CEO Sean D. Keohane sold 91,923 shares of the business's stock in a transaction on Friday, August 7th. The stock was sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the completion of the transaction, the chief executive officer owned 404,134 shares in the company, valued at approximately $34,921,218.94. The trade was a 18.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.08% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. NewEdge Advisors LLC raised its stake in shares of Cabot by 2,559.5% in the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company's stock worth $82,000 after buying an additional 947 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Cabot by 32.5% in the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company's stock worth $36,802,000 after buying an additional 108,645 shares during the period. Empowered Funds LLC grew its position in Cabot by 102.6% during the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company's stock worth $2,341,000 after purchasing an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Cabot by 3.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company's stock valued at $10,145,000 after buying an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock valued at $38,000 after purchasing an additional 364 shares during the period. Institutional investors and hedge funds own 93.18% of the company's stock.

Cabot Price Performance

CBT stock opened at $86.58 on Thursday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The firm has a market cap of $4.47 billion, a P/E ratio of 24.39, a PEG ratio of 11.35 and a beta of 0.84. Cabot has a 1 year low of $58.33 and a 1 year high of $94.53. The stock's 50 day moving average price is $87.93 and its 200 day moving average price is $80.25.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping analysts' consensus estimates of $1.66 by $0.01. The firm had revenue of $982.00 million during the quarter, compared to analysts' expectations of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, sell-side analysts expect that Cabot will post 6.33 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a $0.4725 dividend. The ex-dividend date is Friday, August 28th. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. Cabot's dividend payout ratio (DPR) is presently 53.24%.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source